Potency of Carcinogens Derived from Covalent DNA Binding and Stimulation of DNA Synthesis in Rat Liver

Abstract

In order to investigate the role of the stimulation of cell division for the initiation (and possibly promotion) of liver tumors by chemical carcinogens, the incorporation of radiolabelled thymidine into liver DNA was determined in male rats. Single doses of various levels of aflatoxin B_t, benzidine and carbon tetrachloride (all known to be genotoxic via DNA binding) did not affect cell division, whereas several hepatocarcinogens known not to bind to DNA (alpha-HCH, clofibrate, and 2,3,7,8-tetrachlorodibenzo-p-dioxin) gave rise to a dose-dependent stimulation of liver DNA synthesis within 24 h. An equation combining the influences of mitotic stimulation, expressed as dose required to double the control level of DNA synthesis, and DNA binding potency, expressed as the Covalent Binding Index, correlated well with the carcinogenic potency for both classes of hepatocarcinogens.

References

1. McCann J , Choi E. Yamasaki E and Ames BN (1975) Detection of carcinogens ns mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc Natl Acad Sci (USA) 72:5135–5139.

2. Meselson M and Russell K (1977): Comparisons of carcinogenic and mutagenic potency. In: Origins of Human Cancer., HH Hiatt . JD Watson and JA Winsten (eds). Cold Spring Harbor Laboratory, pp. 1473–1481.

3. Ashby J and Styles JA (1978). Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature 271:452–455.

4. Lutz WK and Schlatter C (1977). Saccharin does not bind to DNA of liver or bladder in the rat. Chem-Biol Interact 19:253–257.

5. Lutz WK (1979). In vivo covalent binding of organic chemicals to DNA as n quantitative indicator in the process of chemical carcinogenesis. Mutat Res 65:289–356.

6. Lutz WK (1982): Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens. In: Biological Reactive Intermediates. Vol. II Part B., R Snyder , DV Parke , JJ Kocsis , DJ Jollow , GG Gibson and CM Witmer (eds). Plenum Press, New York, pp. 1349–1365.

7. Poland A and Glover E (1979) An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat liver protein, ribosomal RNA, and DNA. Cancer Res 39:3341–3341.

8. von Däniken A , Lutz WK and Schlatter C (1981): Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate. Toxicol Letters 7:305–310.

9. Sagelsdorff P , Lutz WK and Schlatter C (1983). The relevance of covalent binding to mouse liver DNA to the carcinogenic action of hexachlorocyclohexane isomers. Corcinogenesis 4:1267–1273.

10.

10. Schulte-Hermann R (1974). Induction of liver growth by xenobiotic compounds and other stimuli. Crit Rev Toxicol 3:97–158.

11.

11. Viviani A and Lutz WK (1978). Modulation of the binding of the carcinogen benzo(a)pyrene to rat liver DNA in vivo by selective induction of microsomal and nuclear aryl hydrocarbon hydroxylase activity. Cancer Res 38:4640–4644.

12.

12. Parodi S , Taningher M and Santi L (1982): Aikaline elution in vivo: Fluorometric analysis in rats; quantitative predictivity of carcinogenicity as compared with other short-term tests. Banbury Report Vol. 13., Cold Spring Harbor Laboratory, pp. 137–155.

13.

13. Parodi S , Taningher M , Boero P and Santi L (1982). Quantitative correlations amongst alkaline DNA fragmentation, DNA covalent binding, mutagenicity in the Ames test and carcinogenicity, for 21 compounds. Mutat Res 93:1–24.